Q4 2024 Earnings Call Transcript March 31, 2025 Bionano Genomics, Inc. reports earnings inline with expectations. Reported ...

Bionano Genomics Inc (BNGO) reports improved gross margins and reduced operating expenses, while facing revenue declines and ...

Discover Bionano Genomics' Q4 2024 earnings insights, focusing on operational efficiency, core customer utilization, and 2025 growth strategies with new ...

SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2024 and revenue outlook ...

Cash, cash equivalents, and available-for-sale securities as of December 31, 2024 were $20.9M, of which $11.4M was subject to certain ...

Analysts estimate that Bionano Genomics will report an earnings per share (EPS) of $-8.40. The announcement from Bionano ...

Bionano Genomics, Inc. has announced a webinar to be held on April 15, 2025, featuring Dr. Guilin Tang, the lead author of a recent study published in the American Journal of Hematology.

Forward-Looking Statements of Bionano Genomics This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as ...

SAN DIEGO, and GREENWOOD, S.C., March 24, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) and Greenwood Genetic Center (GGC) today announced a publication in Genome Research describing ...

Thank you, operator, and good afternoon, everyone. Welcome to the Bionano fourth quarter 2024 financial results conference ...

Good day, and welcome to the Bionano fourth quarter 2024 earnings conference call. Today's conference is being recorded. At this time, I would like to turn the conference over to David Holmes from ...